Jiangxi Sanxin Medtec Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 15, 2021 at 05:33 pm IST
Share
Jiangxi Sanxin Medtec Co.,Ltd. announced earnings results for the nine months ended September 30, 2021. For the nine months, the company announced sales was CNY 826.470 million compared to CNY 681.997 million a year ago. Operating income was CNY 149.963 million compared to CNY 111.249 million a year ago. Net income was CNY 114.500 million compared to CNY 82.057 million a year ago. Basic earnings per share from continuing operations was CNY 0.2906 compared to CNY 0.2083 a year ago.
Jiangxi Sanxin Medtec Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, sales and service of medical devices. The Company's main products include blood purification, infusion, cardiothoracic surgery and diabetes treatment devices, early and mid-stage kidney disease intervention and treatment devices, and vascular intervention devices. The Company's core business is blood purification products, which are used in blood purification treatment for end-stage renal disease (uremia), acute and chronic renal failure, and drug or other substance poisoning. The Company mainly conducts its business in the domestic and foreign markets.
JIANGXI SANXIN MEDTEC CO.,LTD. 
